Pharmaceutical formulations

US10772879B2 · kind B2 · utility

Assignee

• Torrent Pharmaceuticals Limited · IN

Inventors

• Chaitanya Dutt · Gandhinagar, IN
• Jaya Abraham · Gandhinagar, IN
• Vivek Mishra · Gandhinagar, IN
• Amit Kesarwani · Adalaj, IN
• Ramesh Gupta · Prospect, US
• Shailesh Deshpande · Gandhinagar, IN
• Shital Kumar Zambad · Gandhinagar, IN
• Anoop Mathur · Gandhinagar, IN
• Jignesh Kotecha · Gandhinagar, IN
• Sachin Latad · Gandhinagar, IN
• Manish Patel · Toronto, CA
• Anita Chaudhari · Gandhinagar, IN

Key dates

• Filing date: Apr 5, 2016
• Grant date: Sep 15, 2020
• Expiry date: Apr 5, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P3/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to pharmaceutical formulations comprising 1-(2-thien-2′-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.